Induction of autoimmune hepatitis by pegylated interferon alfa-2b in chronic hepatitis C.
Lörke
Julia
J
Klinik für Gastroenterologie, Hepatologie und Infektiologie, Heinrich-Heine-Universität, Düsseldorf, Germany.
Erhardt
Andreas
A
Häussinger
Dieter
D
D000410:Alanine Transaminase / Q000032:analysis; D000998:Antiviral Agents / Q000009:adverse effects*; D001706:Biopsy; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D019693:Hepatitis, Autoimmune / Q000209:etiology*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008099:Liver / Q000473:pathology; D008875:Middle Aged; D011092:Polyethylene Glycols; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D000410:Alanine Transaminase; C417083:peginterferon alfa-2b